Novartis AG
METHODS OF TREATING SJOGREN'S SYNDROME USING A BRUTON'S TYROSINE KINASE INHIBITOR

Abstract:

The present disclosure relates to methods for treating Sjogren's Syndrome disease using a compound of Formula (I) or a pharmaceutically acceptable salt thereof. Also disclosed herein a compound of Formula (I) or a pharmaceutically acceptable salt thereof, for treating Sjogren's Syndrome patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.